| # | Drug | Count |
|---|---|---|
| 0 | IBUPFROFEN | 3 |
| 1 | IBUPROFEN | 3 |
| 2 | IBUPROFEN 200 MG | 3 |
| 3 | IBUPROFEN 200MG | 3 |
| 4 | IBUPROFEN CAPSULE | 3 |
| 5 | IBUPROFEN CAPSULES 200 MG | 3 |
| 6 | IBUPROFEN ORAL | 3 |
| 7 | IBUPROFEN TABLET, FILM COATED | 3 |
| 8 | IBUPROFEN TABLET, FILM-COATED | 3 |
| 9 | IBUPROFEN TABLETS USP, 200MG | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES WITH FLAVOR PACK | 1 | 0.0048 |
| 1 | SORBITOL | 1 | 0.0017 |
| 2 | SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID | 1 | 0.0014 |
| 3 | IPTACOPAN | 1 | 0.0013 |
| 4 | PRUCALOPRIDE | 1 | 0.0004 |
| 5 | NEOMYCIN SULFATE | 1 | 0.0004 |
| 6 | ICATIBANT ACETATE | 1 | 0.0002 |
| 7 | BENZOYL PEROXIDE | 1 | 0.0001 |
| 8 | OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE | 1 | 0.0001 |
| 9 | ERTAPENEM SODIUM | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 4 |
| 1 | Corticosteroid [EPC] | 3 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 2 |
| 3 | GLP-1 Receptor Agonist [EPC] | 2 |
| 4 | Osmotic Laxative [EPC] | 2 |
| 5 | Proton Pump Inhibitor [EPC] | 2 |
| 6 | Alkylating Drug [EPC] | 1 |
| 7 | Aluminum Complex [EPC] | 1 |
| 8 | Anti-coagulant [EPC] | 1 |
| 9 | Antifibrinolytic Agent [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 1 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 2 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |
| 4 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Aluminum Complex [EPC] | 1 | 0.0000 |
| 7 | Iron Chelator [EPC] | 1 | 0.0000 |
| 8 | Rifamycin Antibacterial [EPC] | 1 | 0.0000 |
| 9 | General Anesthetic [EPC] | 1 | 0.0000 |